Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids

doi:10.3748/wjg.v19.i11.1718

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6311)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

441

HTML

3796

Figures (1-4)

225

Tables (1-2)

219

Sum=4681

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

882

Download

748

Sum=1630

Mar 21, 2013 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Mar 21, 2013; 19(11): 1718-1727
Published online Mar 21, 2013. doi: 10.3748/wjg.v19.i11.1718

Table 1 CpG islands hypermethylation of tumor-associated genes in pancreatic fluids

	Age (yr)	Sex	Stage	UCHL1	RUNX3	CDKN2A	IGF2	CACNA1G	AHRR	SFRP1	MGMT	APC	NEUROG1
NC1	68	M		MN	MN	MN	MN	MN	MN	MP	MP	MN	MN
NC2	65	M		MN	MN	MN	MN	MP	MN	MN	MN	MN	MN
NC3	59	M		MN	MN	MP	MN	MN	MN	MN	MN	MN	MP
NC4	70	F		MN	MN	MN	MP	MN	MN	MN	MN	MN	MN
NC5	43	F		MN	MN	MN	MN	MN	MN	MN	MP	MN	MN
NC6	55	M		MN	MN	MN	MN	MP	MN	MN	MN	MN	MN
NC7	49	M		MN	MN	MN	MN	MN	MP	MN	MN	MP	MN
				MN	MN	MN	MN	MN	MN	MN	MN	MN	MN
IP1	71	F		MN	MN	MP	MN	MN	MN	MN	MN	MN	MN
IP2	79	F		MN	MN	MN	MN	MN	MN	MN	MN	MN	MP
IP3	76	M		MN	MP	MN	MN	MN	MN	MN	MP	MN	MN
IP4	75	F		MN	MN	MN	MP	MN	MP	MP	MN	MP	MN
IP5	84	F		MN	MN	MN	MN	MN	MN	MP	MN	MN	MN
IP6	52	M		MN	MN	MP	MN	MN	MN	MP	MP	MN	MN
IP7	62	M		MN	MN	MN	MP	MN	MN	MN	MP	MP	MN
IP8	63	M		MN	MN	MP	MN	MN	MN	MN	MP	MN	MN
				MN	MN	MN	MN	MN	MN	MN	MN	MN	MN
PC1	66	F	IIA	MP	MN	MN	MN	MN	MN	MN	MP	MN	MN
PC2	54	F	III	MN	MP	MN	MN	MN	MN	MN	MN	MN	MN
PC3	66	M	IIB	MP	MP	MN	MN	MN	MN	MP	MN	MP	MP
PC4	67	M	IIB	MP	MN	MN	MN	MP	MN	MN	MN	MP	MN
PC5	71	M	IIB	MN	MP	MP	MN	MN	MN	MN	MN	MN	MN
PC6	49	F	IIA	MP	MP	MN	MN	MN	MN	MP	MN	MP	MP
PC7	73	F	IIB	MP	MN	MN	MN	MN	MP	MP	MN	MN	MN
PC8	75	M	III	MP	MP	MN	MN	MN	MN	MN	MN	MP	MN
PC9	59	M	IIB	MN	MN	MN	MN	MP	MN	MP	MP	MP	MP
PC10	78	F	IIA	MP	MP	MP	MN	MN	MN	MP	MP	MN	MP
PC11	75	F	IIB	MN	MN	MN	MP	MN	MN	MP	MN	MN	MN
PC12	66	M	IV	MP	MP	MP	MN	MN	MN	MP	MN	MP	MP
PC13	70	F	IV	MP	MN	MN	MN	MN	MP	MP	MP	MP	MP
PC14	68	M	IB	MN	MP	MN	MN	MN	MN	MN	MP	MN	MN
PC15	62	M	IIB	MP	MN	MP	MN	MN	MN	MN	MN	MN	MN

NC: Non-cancer; IP: Intraductal papillary and mucinous pancreatic tumour; pancreatic cancer (PC) 1, PC5, PC7, PC8 and PC13 are identical in Tables 1 and 2. MP: Methylation-positive; MN: Methylation-negative.

Table 2 CpG islands hypermethylation of tumor-associated genes in biliary fluids

	Age (yr)	Sex	Stage	UCHL1	RUNX3	CDKN2A	IGF2	CACNA1G	AHRR	SFRP1	MGMT	APC	NEUROG1
NC8	77	M		MN	MN	MN	MN	MN	MN	MN	MP	MN	MN
NC9	69	F		MN	MN	MN	MN	MN	MN	MP	MN	MN	MN
NC10	76	M		MN	MN	MN	MN	MN	MN	MN	MP	MN	MN
NC11	58	M		MN	MN	MN	MN	MN	MN	MN	MN	MN	MN
NC12	41	M		MN	MN	MN	MN	MN	MP	MN	MP	MN	MN
NC13	66	M		MN	MN	MN	MN	MN	MP	MP	MP	MP	MP
NC14	69	F		MN	MN	MN	MN	MN	MP	MP	MP	MN	MP
NC15	71	F		MN	MN	MN	MN	MN	MN	MN	MP	MP	MN
NC16	59	M		MN	MN	MN	MN	MN	MP	MP	MN	MN	MN
NC17	54	F		MN	MN	MN	MN	MN	MN	MN	MN	MP	MP
NC18	67	M		MN	MN	MN	MN	MN	MP	MP	MN	MN	MN
NC19	85	M		MN	MN	MN	MN	MN	MN	MN	MN	MN	MN
NC20	73	F		MN	MN	MN	MN	MN	MN	MP	MN	MN	MN
NC21	80	F		MN	MN	MN	MN	MN	MN	MN	MP	MN	MN
NC22	74	F		MN	MN	MN	MN	MN	MN	MN	MP	MN	MN
NC23	52	M		MN	MN	MN	MN	MN	MN	MN	MN	MN	MN
NC24	64	M		MN	MN	MN	MN	MN	MN	MP	MP	MP	MN
NC25	64	F		MN	MN	MN	MN	MN	MP	MP	MN	MN	MN
				MN	MN	MN	MN	MN	MN	MN	MN	MN	MN
GB1	75	F	IIIB	MP	MP	MP	MP	MP	MP	MN	MN	MN	MN
GB	76	F	IIIB	MN	MP	MP	MP	MP	MP	MN	MN	MP	MN
GB3	62	M	IIIA	MP	MP	MP	MP	MN	MN	MP	MP	MN	MN
GB4	67	M	IVA	MN	MP	MN	MN	MN	MN	MN	MN	MN	MN
GB5	59	F	IIIB	MP	MN	MP	MN	MN	MP	MP	MN	MP	MP
GB6	63	F	II	MP	MN	MP	MN	MN	MP	MP	MN	MP	MP
GB7	77	M	I	MN	MP	MP	MN	MN	MN	MP	MP	MN	MN
GB8	78	M	IIIA	MP	MN	MP	MN	MN	MN	MP	MP	MN	MN
BC1	73	M	I	MN	MP	MN	MP	MN	MP	MP	MN	MN	MN
BC2	80	F	IIA	MP	MP	MN	MN	MN	MP	MP	MP	MN	MN
BC3	71	M	IIB	MP	MN	MN	MN	MP	MP	MP	MN	MN	MN
BC4	75	M	III	MP	MN	MN	MN	MN	MN	MP	MP	MN	MN
BC5	77	M	IIB	MN	MP	MN	MN	MN	MN	MN	MP	MN	MN
BC6	65	M	IIA	MP	MN	MP	MN	MN	MN	MN	MN	MN	MN
BC7	72	M	IIA	MP	MN	MN	MN	MN	MN	MP	MN	MN	MN
BC8	73	F	IV	MP	MP	MN	MN	MN	MP	MN	MN	MN	MN
BC9	76	F	IIA	MP	MP	MN	MP	MP	MP	MP	MN	MN	MN
BC10	74	M	IIB	MP	MN	MN	MN	MN	MP	MN	MP	MN	MP
BC11	66	M	III	MP	MN	MN	MN	MN	MN	MN	MN	MP	MN
BC12	58	F	IIB	MN	MP	MN	MN	MN	MN	MN	MN	MN	MN
PC1	66	F	IIA	MP	MN	MN	MN	MN	MN	MP	MP	MN	MN
PC5	71	M	IIB	MN	MP	MP	MN	MN	MN	MN	MP	MN	MN
PC7	73	F	IIB	MP	MN	MN	MN	MN	MP	MN	MN	MN	MN
PC8	75	M	III	MP	MP	MN	MN	MN	MN	MN	MP	MN	MN
PC13	70	F	IV	MP	MN	MN	MN	MN	MP	MP	MP	MP	MN
PC16	59	M	IIA	MP	MP	MN	MN	MP	MN	MN	MN	MN	MN
PC17	80	F	IIB	MP	MP	MP	MP	MN	MP	MP	MN	MN	MN
PC18	67	M	IB	MN	MP	MN	MN	MN	MP	MN	MP	MN	MN
PC19	63	M	IIA	MP	MN	MN	MN	MN	MN	MN	MP	MP	MN
PC20	78	F	IIB	MN	MN	MP	MN	MN	MP	MN	MN	MN	MN

NC: Non-cancer; GB: Gallbladder cancer; BC: Biliary cancer; pancreatic cancer (PC) 1, PC5, PC7 and PC8 and PC13 are identical in Tables 1 and 2. MP: Methylation-positive; MN: Methylation-negative.

Citation: Kato N, Yamamoto H, Adachi Y, Ohashi H, Taniguchi H, Suzuki H, Nakazawa M, Kaneto H, Sasaki S, Imai K, Shinomura Y. Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids. World J Gastroenterol 2013; 19(11): 1718-1727
URL: https://www.wjgnet.com/1007-9327/full/v19/i11/1718.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i11.1718